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Letter to the Editor 
Clinical Microbiology
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Dear Editor,
Bacteria continuously develop, acquire, and spread numerous 
resistance patterns shortly after new antibiotics reach the mar-
ket. Recently, carbapenem-resistant Enterobacteriaceae (CRE) 
and colistin-resistant Acinetobacter baumannii are emerging, 
which may lead us into the pre-antibiotic era. Pipelines of new 
antibiotics are becoming thinner and thinner across all thera-
peutic areas due to difficulties in innovation and challenges of 
regulatory hurdles. Under such a situation, maintaining antibi-
otic effectiveness in the long term requires not only innovation 
to develop new antibiotics, but also conservation of the effective-
ness of existing antibiotics. 
Antibiotic cycling or rotation consists of the sequential use of 
antibiotics not sharing a common mechanism of resistance, which 
could be considered as a strategy for conservation. Aminoglyco-
side consumption has continuously decreased during the recent 
five years [1]. The rates of amikacin or gentamicin-resistant Kleb-
siella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter 
spp. also showed declining trends according to data from the 
Korean Nationwide Surveillance of Antimicrobial Resistance (KO-
NSAR) program [2]. The decreasing prevalence of amikacin 
and tobramycin resistance in some Gram-negative bacteria was 
associated with decreased consumption levels of these antimi-
crobial agents in a single-center study [3]. Aminoglycosides, ex-
cept amikacin, can be considered as old drugs; however, they 
remain key roles in the treatment of infections. They also pos-
sess potent bactericidal activity against some CRE [4]. 
We investigated the correlation of aminoglycoside consump-
tion and its resistance in P. aeruginosa using a nationwide sur-
veillance and antibiotic prescription database to provide back-
ground data on the effectiveness of antibiotic cycling at the na-
tional level. Data on antibiotic usage in Korea from 2002 to 2013 
were acquired from the database of the National Health Insur-
ance Service-National Sample Cohort (NHIS-NSC), a popula-
tion-based cohort established to provide public health research-
ers and policy makers with representative information regarding 
the utilization of health insurance and health examinations among 
citizens [5]. We also included prescription data for systemic an-
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tibiotics based on the Anatomical Therapeutic Chemical Classi-
fication System in this study. Amount of use was standardized 
by Daily Defined Dose (DDD) and expressed as DDD per 1,000 
inhabitants daily. Gentamicin and amikacin-resistance rates of P. 
aeruginosa isolated from Korean general hospitals were obtained 
from the Korean Antimicrobial Resistance Monitoring System 
[6]. This study was approved by the Institutional Review Board 
of the National Health Insurance Service Ilsan Hospital (NHIMC 
2017-03-026). We analyzed the data using SAS software version 
9.2 (SAS Institute, Cary, NC, USA). The relationship between 
antibiotic use and resistance was evaluated by simple correla-
tion analysis. The significance level was set at P <0.05.
Despite the worsening resistance rates in other antibiotic classes 
in Korea [6], aminoglycosides might be the only ones showing 
decreasing trends of consumption and resistance rates. National 
gentamicin and total aminoglycoside consumption has continu-
ously decreased and shown strong correlations with gentamicin-
resistance rate of P. aeruginosa isolated from general hospitals 
with more than 100 beds (Fig. 1). 
National amikacin consumption has continuously decreased 
after 2006. Amikacin-resistance rate of P. aeruginosa in the same 
year did not correlate with amikacin usage. However, it showed 
strong correlation at two-year intervals (Fig. 2). 
The reason for this difference is currently unclear, but we sus-
pected it to be due to different gentamicin- and amikacin- resis-
tance mechanisms. Gentamicin resistance is mediated mainly 
by aminoglycoside modification, but 16S rRNA methyltransfer-
ase production constitutes a high level of resistance to amino-
glycoside, especially to amikacin [7]. 
Other researchers reported that restriction of gentamicin and 
tobramycin decreased the resistance rate to both antimicrobials 
especially in P. aeruginosa in the 1980s [8, 9]. The study was 
performed during the period of introduction of amikacin and 
emergence of plasmid-mediated resistance to gentamicin. In 
Korea, Ku et al [3] reported that decreasing prevalence of ami-
kacin and tobramycin resistance in P. aeruginosa isolates were 
associated with decreased consumption levels of these antimi-
crobials; but this correlation was not observed with gentamicin. 
This was discordant with our study and that of Lai et al [10], which 
showed good correlation with gentamicin and amikacin. The 
study by Ku et al [3] was a single center analysis from 2001 to 
2011, and could be affected by patients’ characteristics, infec-
tion control policy, and microbiological factors. 
The strength of this study is that it is based on nationwide sur-
veillance and antibiotic prescription database spanning an ex-
tended period; thus the findings are representative of the popu-
lation. This study suggests that less aminoglycoside consump-
tion correlates with less resistance levels, hence the need for an 
antibiotic cycling strategy at the national level. 
Authors’ Disclosure of Potential Conflicts of 
Interest
We have nothing to declare. 
Acknowledgment
This study was supported by a grant (2016-20-001) from the 
National Health Insurance Service Ilsan Hospital. This study ac-
Fig. 1. Correlation of national aminoglycoside usage and gentami-
cin-resistance rates (%) of P. aeruginosa (GEN-R-PAE) isolated from 
general hospitals. Correlation of gentamicin usage and GEN-R-PAE 
(correlation coefficient r=0.83, P =0.0028); correlation of total ami-
noglycoside usage and GEN-R-PAE (r=0.92, P =0.0001).
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Fig. 2. Correlation of national amikacin usage and amikacin-resis-
tance rates (%) of P. aeruginosa (AMK-R-PAE) isolated from gener-
al hospitals. Correlation of amikacin usage and AMK-R-PAE in the 
same year (correlation coefficient r=–0.11, P =0.8192); correlation 
of amikacin usage and AMK-R-PAE with 2-year interval (r=0.77, 
P =0.0145).
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